Digital imaging firm Schick Technologies this month reported a big jump in revenues as the firm's products begin to hit the market. For the year (end-March), Schick posted revenues of $38.5 million, up 139% compared with $16.1 million the year before.
Digital imaging firm Schick Technologies this month reported a big jump in revenues as the firm's products begin to hit the market. For the year (end-March), Schick posted revenues of $38.5 million, up 139% compared with $16.1 million the year before. The company had net income for the year of $2.4 million, compared with a net loss of $352,000 in 1997. The 1998 figures include a one-time patent litigation settlement of $600,000.
Schick reported that sales of its accuDEXA bone densitometer are going well. In addition, the Long Island City, NY, company reported that it received 510(k) clearance from the Food and Drug Administration for an additional application for accuDEXA: use of the system to help physicians determine the risk of fracture. AccuDEXA received its initial 510(k) market clearance in December for assessing bone mineral density (SCAN 4/15/98).
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.